Chinese medical robot developer TMiRob announced on Tuesday that it has completed a series B+ round of financing in the first quarter of 2019 from several investment units of Spinnotec, a state-owned venture capital platform in Shanghai.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.
Register Basic AccountSubscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!
More Info
Already have an account or paid subscription? Log in
